Back to today’s briefing

Story perspectives

Study Shows Daily Peanuts May Cure Severe Allergies

4/26/2025

22 5

Summary

Allergy Relief Breakthrough

A groundbreaking study from King's College London reveals that adults with severe peanut allergies can develop tolerance by consuming small daily doses of peanuts. In the GUPI trial, an impressive 67% of participants successfully tolerated five peanuts after gradual exposure, offering newfound hope for enhancing the quality of life for those affected by this allergy.

Summary

Allergy Market Expansion

The food allergy market is poised for remarkable expansion, projected to reach new heights by 2034. Currently valued at $1.6 billion, it serves 57 million individuals across seven key markets. Pioneering therapies from Aimmune Therapeutics and Novartis promise to enhance long-term tolerance and transform patient experiences, offering hope to many.

1 of 2

Allergy Relief Breakthrough

A groundbreaking study from King's College London reveals that adults with severe peanut allergies can develop tolerance by consuming small daily doses of peanuts. In the GUPI trial, an impressive 67% of participants successfully tolerated five peanuts after gradual exposure, offering newfound hope for enhancing the quality of life for those affected by this allergy.

1 / 2